Sorafenib and disease progression 
Sorafenib and disease progression Patient Reports February 09, 2010
Sorafenib Side Effects Report #4886932-9
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with squamous cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, blood alkaline phosphatase abnormal, disease progression, dysphagia. Sorafenib dosage: 400 MG, BID, ORAL. Patient died on 04/26/2005.
Sorafenib Side Effects Report #5258520-6
Sorafenib side effect was reported by a Physician from ITALY on Dec 21, 2006. Male patient, 55 years of age, weighting 127.9 lb, was diagnosed with sarcoma, stomatitis, dyspnoea, prophylaxis, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dyspnoea, hospitalisation, sarcoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with NISTATIN, DEXAMETHASONE, OMEPRAZOLE, MORFIN, TRAMADOL, PREDNISONE. Patient was hospitalized. Patient died on 01/25/2007.Sorafenib Side Effects Report #5826585-6
Sorafenib side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Male patient, 79 years of age, weighting 233.7 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression. Sorafenib dosage: 400MG Q 12HRS PO. Patient died.
Sorafenib Side Effects Report #5653241-X
Sorafenib side effect was reported by a Physician from CANADA on Feb 22, 2008. Male patient, 68 years of age, weighting 101.4 lb, was diagnosed with renal cell carcinoma, hypertension, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: convulsions local, disease progression, disorientation, dizziness , dyspnoea, faecal incontinence, lung disorder, superinfection, syncope. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COVERSYL, OXYCOCET. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5629397-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2008. Male patient, 67 years of age, weighting 222.7 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: constipation , diabetic complication, disease progression. Sorafenib dosage: 400MG BID PO. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6045345-7
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2009. Female patient, 68 years of age, weighting 93.40 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, mucosal inflammation, nausea
, pain . Sorafenib dosage: 200MG EVERY 12 HOURS PO. During the same period patient was treated with OXALIPLATIN, XELODA. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6099404-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2009. Male patient, weighting 211.2 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, disease progression, gastroenteritis
, pseudocyst. Sorafenib dosage: 400 MG PO BID. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5203429-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 73 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bronchitis
, disease progression, hypotension, pleural effusion, pneumonia . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN. Patient died on 12/04/2006.Sorafenib Side Effects Report #5181014-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 14, 2006. Male patient, 73 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bronchitis
, disease progression, hypotension, pleural effusion, pneumonia . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN. Patient died on 12/04/2006.Sorafenib Side Effects Report #4931032-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2006. Male patient, 65 years of age, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, fatigue, gingival bleeding, metastases to central nervous system, osteonecrosis
, periodontal disease. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with ZOMETA, COLACE, COMBIVENT, DIOVAN, FLOVENT, MARINOL, OXANDRIN, PLENDIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5075103-1
Sorafenib side effect was reported by a Physician from UNITED STATES on July 25, 2006. Male patient, 64 years of age, weighting 157.0 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, carotid artery stenosis, cerebral ischaemia, deep vein thrombosis
, disease progression, lung infiltration, mass. Sorafenib dosage: 400 MG, BID, ORAL. Patient was hospitalized. Patient died on 06/24/2006.Sorafenib Side Effects Report #5202147-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood alkaline phosphatase increased, confusional state, constipation , decreased appetite, dehydration, disease progression, gamma-glutamyltransferase increased, tremor. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMPAZINE, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5295843-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, disease progression, fatigue, hypocalcaemia, hypophosphataemia, lymphopenia, nausea
, non-small cell lung cancer. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 04/04/2007.Sorafenib Side Effects Report #4995083-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 19, 2006. Female patient, 62 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chest pain
, disease progression, herpes virus infection, hydropneumothorax, hypoxia. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5021020-2
Sorafenib side effect was reported by a Physician from UNITED STATES on May 19, 2006. Male patient, 61 years of age, weighting 242.5 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, blood electrolytes abnormal, dehydration, disease progression, dyspnoea, electrocardiogram qt corrected interval prolonged, hyperkalaemia, hyponatraemia, hypotension. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with ALEVE, AMBIEN, COMPAZINE, CASANTHRANOL W, LACTULOSE, OXYCODONE, PEPCID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5032088-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Male patient, 61 years of age, weighting 242.5 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, blood electrolytes abnormal, dehydration, disease progression, dyspnoea, electrocardiogram qt corrected interval prolonged, hyperkalaemia, hyponatraemia. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ALEVE, AMBIEN, COMPAZINE, LACTULOSE, OXYCODONE, PEPCID, TUMS. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4983100-7
Sorafenib side effect was reported by a Consumer or non-health professional from ISRAEL on Apr 06, 2006. Male patient, 71 years of age, weighting 160.9 lb, was diagnosed with neoplasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, disease progression, duodenal ulcer, gastric ulcer, gastrointestinal haemorrhage. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LCV, ATENOLOL, MEGACE, BONDORMIN, XANAGIS. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5151101-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 05, 2006. Male patient, 78 years of age, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, asthma
, oedema, pneumonia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, disease progression, electrocardiogram t wave abnormal, pleural effusion, pneumonia , pneumothorax, pulmonary oedema, respiratory failure. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COREG, PREDNISONE, LASIX, OMNICEF, ASPIRIN. Patient was hospitalized. Patient died on 02/09/2006.Sorafenib Side Effects Report #5176740-6
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2006. Male patient, 78 years of age, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, asthma
, oedema, pneumonia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, disease progression, electrocardiogram t wave abnormal, pleural effusion, pneumonia , pneumothorax, post procedural drainage, pulmonary oedema. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COREG, PREDNISONE, LASIX, OMNICEF, ASPIRIN. Patient was hospitalized and became disabled. Patient died on 02/09/2006.Sorafenib Side Effects Report #5107888-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 26, 2006. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, hypercholesterolaemia, peripheral vascular disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aneurysm
, blister, disease progression, gangrene, peripheral vascular disorder, pulse abnormal, rash , skin discolouration. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEVOTHYROXINE, LISINOPRIL, LIPITOR, TRENTAL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5114152-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Oct 18, 2005. Female patient, 77 years of age, weighting 202.8 lb, was diagnosed with metastatic renal cell carcinoma, platelet aggregation abnormal, gastrointestinal disorder, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bone pain, disease progression, lung neoplasm, metastatic renal cell carcinoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with AGGRENOX, PROTONIX, SOTOLOL, AVAPRO, ALLOPURINOL, HYDROCHLOROTHIAZIDE, LASIX, ARANESP. Patient recovered.Sorafenib Side Effects Report #5526610-6
Sorafenib side effect was reported by a Physician from POLAND on Nov 21, 2007. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma, diabetes mellitus, arrhythmia
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, disease progression. Sorafenib dosage: unknown. During the same period patient was treated with ENARENAL, DURAGESIC, GLUCOBAY, GLUFORMIN, BIOSOTAL, MONONIT. Patient died on 05/28/2007.Sorafenib Side Effects Report #5618569-8
Sorafenib side effect was reported by a Physician from POLAND on Jan 30, 2008. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma, diabetes mellitus, arrhythmia
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, disease progression. Sorafenib dosage: unknown. During the same period patient was treated with ENARENAL, DURAGESIC, GLUCOBAY, GLUFORMIN, BIOSOTAL, MONONIT. Patient died on 05/28/2007.Sorafenib Side Effects Report #4880369-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 71 years of age, weighting 175.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression. Sorafenib dosage: unknown. During the same period patient was treated with NORVASC, LIPITOR, FOLTX, ASPIRIN, OXYCONTIN, PERCOCET, LEVSIN. Patient died on 12/24/2005.
Sorafenib Side Effects Report #5129543-2
Sorafenib side effect was reported by a Physician from ITALY on Oct 11, 2006. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with metastatic renal cell carcinoma, benign prostatic hyperplasia, hypertension, haemoptysis, pain
, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, metastatic renal cell carcinoma. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, OMNIC, LASIX, TRANEX, DELTACORTENE, ACTRAPID. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5156032-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Nov 28, 2005. Female patient, 69 years of age, weighting 194.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: candidiasis, cardiac arrest
, disease progression, metastases to peritoneum, metastatic renal cell carcinoma, nausea , oesophageal stenosis, pleural effusion. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient died on 12/17/2005.Sorafenib Side Effects Report #5141124-3
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, disease progression, diverticulum, dysphagia, gastric haemorrhage, gastrointestinal haemorrhage, haematochezia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5157117-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, disease progression, diverticulitis, dysphagia, feeding tube complication, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5103844-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 17, 2006. Male patient, 67 years of age, weighting 94.80 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, pain
, nephrolithiasis, iron deficiency, constipation and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, disease progression, hepatic failure, metastatic renal cell carcinoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with PROPRANOLOL, PROTONIX, OXYCODONE, FLOMAX, ALLOPURINOL, HYDROCODONE BITARTRATE, FERROUS SULPHATE, COLACE. Patient died on 12/22/2005.Sorafenib Side Effects Report #5106466-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 17, 2006. Male patient, 67 years of age, weighting 94.80 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, pain
, nephrolithiasis, iron deficiency, constipation and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, anaemia, ascites, blood iron decreased, disease progression, dizziness , hepatic failure, metastases to liver, metastatic renal cell carcinoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with PROPRANOLOL, PROTONIX, OXYCODONE, FLOMAX, ALLOPURINOL, HYDROCODONE BITARTRATE, FERROUS SULPHATE, COLACE. Patient died on 12/22/2005.Sorafenib Side Effects Report #5534285-5
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Dec 03, 2007. Male patient, 67 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, back pain
, disease progression, hypercalcaemia, pleural effusion. Sorafenib dosage: 400 MG PO QD. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5574274-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Male patient, 67 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression. Sorafenib dosage: 400MG PO QD. Patient died on 12/14/2007.
Sorafenib Side Effects Report #5194631-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 26, 2005. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with metastatic renal cell carcinoma, constipation
, dysphagia, pain , sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cancer pain, disease progression, tachycardia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with SENNA, NEXIUM, OXYCONTIN, HYDROMORPHONE, MIRALAX, REGLAN, BENADRYL, IBUPROFEN. Patient was hospitalized. Patient died on 09/30/2005.Sorafenib Side Effects Report #4951933-9
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on Mar 07, 2006. Male patient, 65 years of age, weighting 191.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, adrenal disorder, asthenia, cardiac disorder, computerised tomogram abnormal, condition aggravated, disease progression. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ZOCOR, DEXERYL, IMODIUM. Patient was hospitalized. Patient died on 01/28/2006.Sorafenib Side Effects Report #4954672-3
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on Mar 07, 2006. Male patient, 65 years of age, weighting 191.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, asthenia, blood lactate dehydrogenase increased, cardiac disorder, computerised tomogram abnormal, disease progression. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ZOCOR, DEXERYL PIERRE FABRE, IMODIUM, BIAFINE. Patient was hospitalized. Patient died on 01/28/2006.
Sorafenib Side Effects Report #5009979-0
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on May 10, 2006. Male patient, 65 years of age, weighting 191.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, adrenal disorder, asthenia, cardiac disorder, culture urine positive, disease progression. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ZOCOR, DEXERYL, IMODIUM, BIAFINE. Patient was hospitalized. Patient died on 01/28/2006.Sorafenib Side Effects Report #4919768-0
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on Feb 08, 2006. Male patient, 64 years of age, weighting 191.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, asthenia, disease progression, hepatojugular reflux, hepatomegaly, mediastinum neoplasm. Sorafenib dosage: unknown. During the same period patient was treated with ZOCOR, DEXERYL, IMODIUM, BIAFINE, TIORFAN. Patient was hospitalized. Patient died on 01/28/2006.Sorafenib Side Effects Report #5114836-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma, pain
, dyspnoea, hypertension, cough, ex-smoker, sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, bowel sounds abnormal, cough, disease progression, dyspnoea, electrocardiogram poor r-wave progression, gastric perforation, gastrointestinal perforation, lobar pneumonia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5120313-8
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 63 years of age, weighting 147.7 lb, was diagnosed with metastatic renal cell carcinoma, pain
, dyspnoea, hypertension, cough, ex-smoker, sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, gastric perforation, lobar pneumonia, metastatic renal cell carcinoma, peritonitis, respiratory failure, white blood cell count increased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5120856-7
Sorafenib side effect was reported by a Physician from ITALY on Aug 16, 2006. Male patient, 63 years of age, weighting 176.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea. Sorafenib dosage: unknown. During the same period patient was treated with INTERFERON ALPHA. Patient was hospitalized. Patient died on 08/25/2006.
Sorafenib Side Effects Report #5121598-4
Sorafenib side effect was reported by a Physician from ITALY on Aug 16, 2006. Male patient, 63 years of age, weighting 176.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea. Sorafenib dosage: unknown. During the same period patient was treated with INTERFERON ALPHA. Patient was hospitalized. Patient died on 08/25/2006.
Sorafenib Side Effects Report #5128497-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 63 years of age, weighting 147.7 lb, was diagnosed with metastatic renal cell carcinoma, pain
, dyspnoea, hypertension, cough, ex-smoker, sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, gastric perforation, lobar pneumonia, metastatic renal cell carcinoma, peritonitis, respiratory failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5143743-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2006. Male patient, 63 years of age, weighting 147.7 lb, was diagnosed with metastatic renal cell carcinoma, pain
, dyspnoea, hypertension, cough, ex-smoker, sleep disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, disease progression, electrocardiogram poor r-wave progression, gastric perforation, lobar pneumonia, lymphadenopathy, metastatic renal cell carcinoma, nausea . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #4919356-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, dyspnoea, intestinal perforation, lobar pneumonia, lymphadenopathy, metastases to liver, oedema peripheral, peritonitis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DECADRON SRC, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN EXPECTORANT W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.
Sorafenib Side Effects Report #4927902-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, intestinal perforation, lobar pneumonia, metastases to small intestine, myocardial infarction, oedema, peritonitis, pleural effusion, respiratory failure. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DECADRON SRC, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN EXPECTORANT W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.
Sorafenib Side Effects Report #4958897-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, intestinal perforation, lobar pneumonia, lymphadenopathy, metastases to liver, nausea
, neoplasm progression, oedema peripheral. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with DECADRON, ADVAIR DISKUS, COMBIVENT, LISINOPRIL, PHENERGAN EXPECTORANT W, NICOTINE, MAALOX FAST BLOCKER, AMBIEN. Patient was hospitalized. Patient died on 01/14/2006.Sorafenib Side Effects Report #5194737-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Nov 10, 2005. Female patient, 62 years of age, weighting 92.59 lb, was diagnosed with metastatic renal cell carcinoma, analgesic effect, antiemetic supportive care, vomiting, hypertension, oedema and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure congestive, congestive cardiomyopathy, dilatation atrial, disease progression, electrocardiogram qt prolonged, electrocardiogram st-t change, gastritis erosive, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with HYDROCODONE BITARTRATE, ATIVAN, COMPAZINE, METOPROLOL SUCCINATE, LASIX. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4949939-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 07, 2006. Female patient, 62 years of age, weighting 91.50 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure decreased, cardiac failure congestive, cardiomegaly, dilatation atrial, disease progression, ejection fraction decreased, electrocardiogram qt prolonged, electrocardiogram st segment abnormal. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with HYDROCODONE, ATIVAN, COMPAZINE, METOPROLOL, LASIX, GLYBURIDE, SYNTHROID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4982615-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 06, 2006. Female patient, 62 years of age, weighting 91.50 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure diastolic decreased, blood urea increased, cardiac failure congestive, cardiomegaly, congestive cardiomyopathy, dilatation atrial, disease progression, ejection fraction decreased. Sorafenib dosage: unknown. During the same period patient was treated with HYDROCODONE, ATIVAN, COMPAZINE, METOPROLOL SUCCINATE, LASIX, GLYBURIDE, SYNTHROID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4872698-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Female patient, 58 years of age, weighting 118.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood creatinine increased, blood glucose increased, blood urea increased, blood urea nitrogen/creatinine ratio increased, carbon dioxide decreased, disease progression, hepatic failure, hyperbilirubinaemia. Sorafenib dosage: unknown. During the same period patient was treated with DITROPAN, EVISTA, HYZAAR. Patient recovered.
Sorafenib Side Effects Report #4880366-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 28, 2005. Female patient, 58 years of age, weighting 118.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood creatinine increased, blood glucose increased, blood urea increased, blood urea nitrogen/creatinine ratio increased, carbon dioxide decreased, dehydration, disease progression, hepatic failure. Sorafenib dosage: unknown. During the same period patient was treated with DITROPAN, EVISTA, HYZAAR. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5121562-5
Sorafenib side effect was reported by a Physician from SWITZERLAND on Sept 28, 2006. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, adrenal insufficiency, prophylaxis against gastrointestinal ulcer, metastases to bone, hypomagnesaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, hypocalcaemia, hypokalaemia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with HYDROCORTONE, NEXIUM, ZOMETA, MAGNESIOCARD. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5109991-7
Sorafenib side effect was reported by a Physician from ITALY on May 26, 2006. Male patient, 53 years of age, was diagnosed with metastatic renal cell carcinoma, biliary tract disorder, prophylaxis against gastrointestinal ulcer, inflammation, analgesic effect and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, disease progression, hypovolaemic shock, pancreatitis haemorrhagic, peritoneal necrosis. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG. During the same period patient was treated with DEURSIL, OMEPRAZOLE, MEDROL, CONTRAMAL. Patient was hospitalized. Patient died on 06/04/2006.Sorafenib Side Effects Report #5043043-X
Sorafenib side effect was reported by a Consumer or non-health professional from ITALY on June 19, 2006. Male patient, 52 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, disease progression, hypovolaemic shock, mechanical ileus, pancreatitis haemorrhagic, pancreatitis necrotising, peritoneal necrosis. Sorafenib dosage: unknown. During the same period patient was treated with DEURSIL, OMEPRAZOLE, MEDROL ACETATE, CONTRAMAL. Patient was hospitalized. Patient died on 06/04/2006.Sorafenib Side Effects Report #5108825-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood calcium decreased, disease progression, haemoglobin decreased, headache
, hyponatraemia, musculoskeletal pain, paraesthesia, wound dehiscence. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5158391-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood calcium decreased, disease progression, haemoglobin decreased, headache , hypocalcaemia, hyponatraemia, infection . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5165365-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood urea decreased, disease progression, haemoglobin decreased, headache , hypocalcaemia, hyponatraemia, infection . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4888254-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood sodium decreased, blood urea decreased, disease progression, haemoglobin decreased, wound dehiscence. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4953122-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, weighting 173.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, disease progression, duodenal neoplasm, fall , fatigue, gastrointestinal haemorrhage, haemoglobin decreased. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with OXYCONTIN, OXYCODONE, TEMAZEPAM, AMLODIPINE, KLONOPIN, DIOVAN, ATARAX, NPH INSULIN. Patient died on 11/22/2005.Sorafenib Side Effects Report #4805504-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Oct 06, 2005. Female patient, 79 years of age, weighting 178.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, fall
, inappropriate antidiuretic hormone secretion, metastases to central nervous system, metastatic neoplasm, orthostatic hypotension, post procedural nausea, subarachnoid haemorrhage. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, ANZEMET, ATIVAN, COMPAZINE, ZOFRAN, ZESTRIL, FOLIC ACID, CENTRUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5059847-3
Sorafenib side effect was reported by a Physician from UNITED STATES on July 11, 2006. Male patient, 77 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disease progression, mental status changes, metastases to central nervous system, tumour haemorrhage. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with TEMADOR. Patient was hospitalized. Patient died on 07/09/2006.
Sorafenib Side Effects Report #5127514-3
Sorafenib side effect was reported by a Physician from UNITED STATES on June 12, 2006. Female patient, 77 years of age, weighting 125.7 lb, was diagnosed with metastatic malignant melanoma, hypertension, anxiety
, pneumonia aspiration and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: agitation, delirium, disease progression, intraocular melanoma, loss of consciousness, mental status changes, metastases to abdominal cavity, metastases to central nervous system, metastases to lung. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MOXIFLOXACIN, LISINOPRIL, XANAX, ZOSYN, METOPROLOL TARTRATE, PROTONIX, ATIVAN, CEREBYX. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5129577-8
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Sept 21, 2006. Female patient, 54 years of age, was diagnosed with metastatic malignant melanoma, hyperkinetic heart syndrome and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, epilepsy
, loss of consciousness. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, TEMERIT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5129637-1
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Sept 21, 2006. Female patient, 54 years of age, was diagnosed with metastatic malignant melanoma, hyperkinetic heart syndrome and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, epilepsy
, metastases to central nervous system. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, TEMERIT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5021723-X
Sorafenib side effect was reported by a Physician from UNITED STATES on May 26, 2006. Female patient, 46 years of age, weighting 156.7 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, brain oedema, cerebral haemorrhage, decreased appetite, disease progression, electrolyte imbalance, epistaxis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with EFFEXOR, AVALIDE, COMPAZINE, VICODIN ES, DILAUDID, AQUABID DM. Patient was hospitalized. Patient died on 03/03/2006.
Sorafenib Side Effects Report #5032985-7
Sorafenib side effect was reported by a Physician from UNITED STATES on June 07, 2006. Female patient, 46 years of age, weighting 156.7 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, cerebral haemorrhage, decreased appetite, depressed level of consciousness, disease progression, electrolyte imbalance, epistaxis. Sorafenib dosage: unknown. During the same period patient was treated with DACARBAZINE, EFFEXOR, AVALIDE, COMPAZINE, VICODIN ES, DILAUDID, AQUABID DM. Patient was hospitalized. Patient died on 03/03/2006.
Sorafenib Side Effects Report #5202112-1
Sorafenib side effect was reported by a Physician from FRANCE on Jan 04, 2007. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma, pain
, constipation , anxiety and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood pressure increased, condition aggravated, cytolytic hepatitis, deep vein thrombosis , disease progression, metastatic malignant melanoma, pelvic venous thrombosis, pulmonary embolism . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 400 MG. During the same period patient was treated with DACARBAZINE, SOLUPRED, MORPHINE, ACTISKENAN, DUPHALAC, ATARAX, LEXOMIL. Patient was hospitalized. Patient died on 08/03/2006.Sorafenib Side Effects Report #5159533-5
Sorafenib side effect was reported by a Physician from UNITED STATES on May 22, 2006. Female patient, 44 years of age, weighting 242.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, disease progression, hepatic failure, hypotension, respiratory distress, sinus tachycardia, thrombocytopenia, white blood cell count increased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with WELLBUTRIN, EFFEXOR, KLONOPIN, TYLENOL, REGULAR INSULIN, AMBIEN, STATIN. Patient was hospitalized. Patient died on 05/21/2006.
Sorafenib Side Effects Report #6071595-X
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2009. Female patient, 76 years of age, was diagnosed with metastases to central nervous system and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression. Sorafenib dosage: 200MG/ BID. Patient died on 10/24/2008.
Sorafenib Side Effects Report #4886933-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with mesothelioma
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea. Sorafenib dosage: 400 MG, BID, ORAL. Patient died on 07/01/2005.Sorafenib Side Effects Report #5150267-X
Sorafenib side effect was reported by a Physician from FRANCE on Mar 03, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with malignant melanoma, metastatic malignant melanoma, hypertension, pyrexia, unevaluable event and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, disease progression, epistaxis, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DACARBAZINE, TEMERIT, EFFERALGAN, FLAMAZINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5049678-2
Sorafenib side effect was reported by a Consumer or non-health professional from AUSTRALIA on June 28, 2006. Female patient, 47 years of age, weighting 135.6 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: agitation, cerebral haemorrhage, discomfort, disease progression, grand mal convulsion, muscle twitching, neuropathy peripheral, pain
, unresponsive to stimuli. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, MS CONTIN, GABAPENTIN, ORDINE, DEXAMETHASONE, DOTHIEPIN HYDROCHLORIDE, ACETAMINOPHEN, BRUFEN. Patient was hospitalized. Patient died on 06/20/2006.Sorafenib Side Effects Report #5155000-3
Sorafenib side effect was reported by a Physician from AUSTRALIA on May 11, 2006. Female patient, 47 years of age, weighting 136.7 lb, was diagnosed with malignant melanoma, analgesic effect and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: agitation, cerebral haemorrhage, disease progression, grand mal convulsion, malignant melanoma, pain management, unresponsive to stimuli, vith nerve paralysis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with FENTANYL, MS CONTIN, MS CONTIN, MS CONTIN, MS CONTIN, GABAPENTIN, ORDINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 06/20/2006.
Sorafenib Side Effects Report #5157242-X
Sorafenib side effect was reported by a Physician from AUSTRALIA on May 11, 2006. Female patient, 47 years of age, weighting 136.7 lb, was diagnosed with malignant melanoma, analgesic effect and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cancer pain, cerebral haemorrhage, disease progression, malignant melanoma. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with FENTANYL, MS CONTIN, MS CONTIN, MS CONTIN, MS CONTIN, GABAPENTIN, ORDINE, DEXAMETHASONE. Patient was hospitalized. Patient died on 06/20/2006.
Sorafenib Side Effects Report #5043041-6
Sorafenib side effect was reported by a Consumer or non-health professional from AUSTRALIA on June 21, 2006. Female patient, 47 years of age, weighting 135.6 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: agitation, aphasia
, cerebral haemorrhage, confusional state, disease progression, glasgow coma scale abnormal, grand mal convulsion, hemiplegia, muscle twitching. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, MS CONTIN, GABAPENTIN, ORDINE, DEXAMETHASONE, DOTHIEPIN HYDROCHLORIDE, ACETAMINOPHEN, BRUFEN. Patient was hospitalized. Patient died on 06/19/2006.Sorafenib Side Effects Report #5338482-3
Sorafenib side effect was reported by a Physician from SPAIN on May 24, 2007. Male patient, weighting 149.9 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5360770-5
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on June 12, 2007. Female patient, 73 years of age, weighting 149.9 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, fatigue, hepatic neoplasm malignant. Sorafenib dosage: unknown. Patient died on 06/10/2007.
Sorafenib Side Effects Report #5029088-4
Sorafenib side effect was reported by a Physician from HONG KONG on June 07, 2006. Male patient, 72 years of age, weighting 166.7 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, hepatic neoplasm malignant. Sorafenib dosage: 400 MG, BID, ORAL. Patient died on 05/28/2006.
Sorafenib Side Effects Report #5032035-2
Sorafenib side effect was reported by a Physician from HONG KONG on June 07, 2006. Male patient, 72 years of age, weighting 166.7 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, hepatic neoplasm malignant. Sorafenib dosage: 400 MG, BID, ORAL. Patient died on 05/28/2006.
Sorafenib Side Effects Report #5258530-9
Sorafenib side effect was reported by a Physician from CANADA on Feb 28, 2007. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with hepatic neoplasm malignant, gastrooesophageal reflux disease, pain
, hypercholesterolaemia, diabetes mellitus, hypertension, seasonal allergy and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve stenosis, arteriovenous malformation , atrial fibrillation , bundle branch block left, dehydration, dilatation atrial, disease progression, electrocardiogram t wave abnormal, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, PROTONIX, OXYCONTIN, LIPITOR, ACTOS, HYDROCHLOROTHIAZIDE, LORATADINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5136997-4
Sorafenib side effect was reported by a Physician from CANADA on May 02, 2006. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with hepatic neoplasm malignant, gastrooesophageal reflux disease, pain
, hypercholesterolaemia, diabetes mellitus, atrial fibrillation , hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve stenosis, arteriovenous malformation , atrial fibrillation , dehydration, dilatation atrial, disease progression, gastrointestinal haemorrhage, hypercalcaemia, mitral valve stenosis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, PROTONIX, OXYCONTIN, LIPITOR, ACTOS, TOPROL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5133714-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 21, 2006. Male patient, 68 years of age, weighting 200.6 lb, was diagnosed with hepatic neoplasm malignant, nausea
, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain , candidiasis, disease progression, dystonia , hepatic pain, hepatosplenomegaly, hiccups, metastatic neoplasm, mucosal inflammation. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, COMPAZINE, METOPROLOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5178963-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 25, 2006. Female patient, 47 years of age, weighting 240.3 lb, was diagnosed with hepatic neoplasm malignant, nausea
, insomnia, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , diarrhoea, disease progression, dyspnoea, malignant neoplasm progression, nausea , neutrophil count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, ZOFRAN, LORAZEPAM, FENTANYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5972740-4
Sorafenib side effect was reported by a Physician from MEXICO on Nov 24, 2008. Male patient, 41 years of age, weighting 249.1 lb, was diagnosed with hepatic neoplasm malignant, anaemia, oesophagitis, cholestasis, haemorrhoids, muscular weakness and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, ascites, asthenia, diarrhoea, disease progression, dysphagia, dyspnoea, encephalopathy. Sorafenib dosage: unknown. During the same period patient was treated with EPOGEN, OMEPRAZOLE, URSODESOXYCHOLIC ACID, LIDOCAINE AND HYDROCORTISONE, VITAMIN SUPPLEMENTATION, RANITIDINE, HEPA MERZ. Patient was hospitalized. Patient died on 04/14/2008.Sorafenib Side Effects Report #5447306-5
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, disease progression, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #6071596-1
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2009. Female patient, 62 years of age, was diagnosed with glioma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: brain neoplasm, disease progression. Sorafenib dosage: 200MG/ BID. During the same period patient was treated with TEMOZOLOMIDE. Patient died on 07/12/2008.
Sorafenib Side Effects Report #5602066-X
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, 49 years of age, weighting 231.5 lb, was diagnosed with glioblastoma multiforme and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, disease progression, dyspnoea, failure to thrive, large intestine perforation, malaise, pneumatosis intestinalis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ERLOTINIB, DECADRON, PROVIGIL, KEPPRA, LASIX, ONDANSETRON, LOPERAMIDE. Patient was hospitalized. Patient died on 05/08/2007.Sorafenib Side Effects Report #5073306-3
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2006. Male patient, 54 years of age, weighting 130.1 lb, was diagnosed with gastrointestinal stromal tumour, pain
, deep vein thrombosis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abscess , decubitus ulcer, deep vein thrombosis , disease progression, hypotrichosis, nausea . Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with DURAGESIC, LOVENOX. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5078773-7
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Male patient, 54 years of age, weighting 130.0 lb, was diagnosed with gastrointestinal neoplasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abscess
, decubitus ulcer, deep vein thrombosis , disease progression, hypotrichosis, nausea . Sorafenib dosage: unknown. During the same period patient was treated with DURAGESIC, LOVENOX. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5877978-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 04, 2008. Female patient, 60 years of age, weighting 105.8 lb, was diagnosed with bile duct cancer, abdominal pain
, herpes simplex , insomnia, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, chest discomfort, chest pain , cholangitis, disease progression, dysgeusia, electrocardiogram qt interval, electrocardiogram qt prolonged, oedema peripheral. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with VORINOSTAT, MS CONTIN, DILAUDID, ZOVIRAX, LORAZEPAM, ATENOLOL, ADVIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5884728-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Sept 11, 2008. Female patient, 60 years of age, weighting 105.8 lb, was diagnosed with bile duct cancer, abdominal pain
, herpes simplex , insomnia, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, bile duct obstruction, blood alkaline phosphatase, blood bilirubin increased, chills, cholangitis, disease progression, dysgeusia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with VORINOSTAT, MS CONTIN, DILAUDID, ZOVIRAX, LORAZEPAM, ATENOLOL, ADVIL. Patient was hospitalized. Patient died on 08/29/2008.Sorafenib Side Effects Report #4883973-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with anaplastic thyroid cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression, infection
, syncope. Sorafenib dosage: 400 MG, BID, ORAL. Patient recovered.Sorafenib Side Effects Report #5941466-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 28, 2008. Male patient, 61 years of age, weighting 141.1 lb, was diagnosed with adenocarcinoma pancreas and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain upper, asthenia, catatonia, disease progression, drooling, dysarthria, dyskinesia, dysphagia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with GEMCITABINE, REGLAN, COMPAZINE, NORCO, COUMADIN. Patient was hospitalized and became disabled. Patient recovered.
Sorafenib Side Effects Report #5176769-8
Sorafenib side effect was reported by a Physician from SWITZERLAND on May 15, 2006. Male patient, 75 years of age, weighting 152.1 lb, was diagnosed with abdominal pain
, insomnia, infection prophylaxis, arrhythmia , thrombosis prophylaxis, routine health maintenance, prophylaxis against gastrointestinal ulcer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain , disease progression, dyspnoea, nausea . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with TRAMADOL, ZOLPIDEM TARTRATE, TAVANIC, TENORMIN, PLAVIX, PREDNISONE, NEXIUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5119289-9
Sorafenib side effect was reported by a Physician from FRANCE on June 13, 2006. Female patient, 66 years of age, was diagnosed with depression
, insomnia, back pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, disease progression, dyspnoea, malnutrition, tachycardia. Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, ZOLPIDEM TARTRATE, IXPRIM, DIANTALVIC, TOPALGIC, SKENAN, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5043040-4
Sorafenib side effect was reported by a Consumer or non-health professional from AUSTRIA on June 19, 2006. Female patient, 66 years of age, weighting 198.4 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arrhythmia
, disease progression, haemorrhage, metastasis. Sorafenib dosage: 600 MG, TOTAL DAILY, ORAL. During the same period patient was treated with GLUCOPHAGE, AVANDIA, HYDROCORTONE, FOSICOMB, FOSITENS, ASTONIN H. Patient died on 03/22/2006.Sorafenib Side Effects Report #5050389-8
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on June 23, 2006. Male patient, 64 years of age, weighting 99.21 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disease progression. Sorafenib dosage: 400 MG, ORAL. During the same period patient was treated with LEXOMIL, IMOVANE, ATHYMIL, GLUCOPHAGE, LANTUS, ACETAMINOPHEN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5113471-2
Sorafenib side effect was reported by a Physician from FRANCE on Feb 08, 2006. Male patient, 61 years of age, weighting 112.4 lb, was diagnosed with anxiety
, pain , abdominal discomfort, abdominal pain , osteolysis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, anxiety , asthenia, disease progression, dry mouth, erythema, fungal infection . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, IXPRIM, METEOSPASMYL, BEDELIX, MAALOX FAST BLOCKER, LYTOS, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5118338-1
Sorafenib side effect was reported by a Physician from FRANCE on Feb 08, 2006. Male patient, 61 years of age, weighting 112.4 lb, was diagnosed with anxiety
, pain , abdominal discomfort, abdominal pain , osteolysis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, disease progression, dry mouth, erythema, fungal infection , liver disorder, mucosal inflammation. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, IXPRIM, METEOSPASMYL, BEDELIX, MAALOX FAST BLOCKER, LYTOS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5125853-3
Sorafenib side effect was reported by a Physician from FRANCE on Feb 08, 2006. Male patient, 61 years of age, weighting 112.4 lb, was diagnosed with anxiety
, pain , abdominal discomfort, abdominal pain , osteolysis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, anxiety , asthenia, disease progression, dry mouth, erythema, fungal infection . Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with LEXOMIL, IXPRIM, METEOSPASMYL, BEDELIX, MAALOX FAST BLOCKER, LYTOS, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.